Auspex Pharma Raises $12M

7/20/10

Vista, CA-based Auspex Pharmaceuticals has raised $12 million from investors, according to a recent regulatory filing. As I noted when the company arranged a $2 million financing in March, Auspex is developing deuterium-based analogs of clinically validated drugs in multiple therapeutic areas. The deuterium replaces metabolically sensitive hydrogen atoms to create novel therapeutics with “very attractive product profiles.” The investors were not identified, but Auspex previously raised almost $13.9 million in a previous round from Thomas, McNerney & Partners, CMEA Ventures, and Costa Verde Capital.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @

By posting a comment, you agree to our terms and conditions.